Showing results (321-330 of 401) with videos related to
Sort By:
Pageof 41
The Oncologist|April 15, 2021
Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19Isaac A Klein, Shoshana M Rosenberg, Kerry L Reynolds, et al.Breast Cancer Research and Treatment|June 13, 2021
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)Kathryn J Ruddy, Yue Zheng, Nabihah Tayob, et al.Plos One|March 13, 2020
Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patientsMichelle Rath, Qiyuan Li, Huili Li, et al.Breast (Edinburgh, Scotland)|February 10, 2015
Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?Olivia Pagani, Monica Ruggeri, Silvia Manunta, et al.Breast (Edinburgh, Scotland)|September 7, 2013
Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statementPatricia A Ganz, Cheng Har Yip, Julie R Gralow, et al.ESMO Open|November 11, 2020
Body weight and return to work among survivors of early-stage breast cancerAntonio Di Meglio, Gwenn Menvielle, Agnes Dumas, et al.Journal of the National Cancer Institute|May 19, 2026
Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancerGuilherme Nader-Marta, Yue Zheng, Shoshana M Rosenberg, et al.JCO Precision Oncology|June 26, 2023
Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus TrastuzumabMarla Lipsyc-Sharf, Esha Jain, Laura C Collins, et al.JAMA Oncology|September 4, 2020
Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical TrialSara M Tolaney, Romualdo Barroso-Sousa, Tanya Keenan, et al.JAMA Network Open|September 23, 2022
Contraceptive Use in Premenopausal Women With Early Breast CancerMatteo Lambertini, Claudia Massarotti, Julie Havas, et al.Pageof 41